Kayagaki N - Search Results

1

Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity.

Nakayama M, Kayagaki N, Yamaguchi N, Okumura K, Yagita H. Nakayama M, et al. Among authors: kayagaki n. J Exp Med. 2000 Nov 6;192(9):1373-80. doi: 10.1084/jem.192.9.1373. J Exp Med. 2000. PMID: 11067885 Free PMC article.

2

Multiple pathways of TWEAK-induced cell death.

Nakayama M, Ishidoh K, Kayagaki N, Kojima Y, Yamaguchi N, Nakano H, Kominami E, Okumura K, Yagita H. Nakayama M, et al. Among authors: kayagaki n. J Immunol. 2002 Jan 15;168(2):734-43. doi: 10.4049/jimmunol.168.2.734. J Immunol. 2002. PMID: 11777967

3

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.

Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Kayagaki N, Yagita H, Okumura K. Takeda K, et al. Among authors: kayagaki n. J Exp Med. 2002 Jan 21;195(2):161-9. doi: 10.1084/jem.20011171. J Exp Med. 2002. PMID: 11805143 Free PMC article.

4

Suppression of antibody production by TNF-related apoptosis-inducing ligand (TRAIL).

Kayagaki N, Yamaguchi N, Abe M, Hirose S, Shirai T, Okumura K, Yagita H. Kayagaki N, et al. Cell Immunol. 2002 Oct;219(2):82-91. doi: 10.1016/s0008-8749(02)00602-0. Cell Immunol. 2002. PMID: 12576026

5

Metalloproteinase-mediated release of human Fas ligand.

Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H. Kayagaki N, et al. J Exp Med. 1995 Dec 1;182(6):1777-83. doi: 10.1084/jem.182.6.1777. J Exp Med. 1995. PMID: 7500022 Free PMC article.

6

Antitumor effect of locally produced CD95 ligand.

Seino K, Kayagaki N, Okumura K, Yagita H. Seino K, et al. Among authors: kayagaki n. Nat Med. 1997 Feb;3(2):165-70. doi: 10.1038/nm0297-165. Nat Med. 1997. PMID: 9018234

7

Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.

Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, Yagita H. Kayagaki N, et al. J Immunol. 1999 Mar 1;162(5):2639-47. J Immunol. 1999. PMID: 10072506

8

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs.

Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H. Kayagaki N, et al. J Exp Med. 1999 May 3;189(9):1451-60. doi: 10.1084/jem.189.9.1451. J Exp Med. 1999. PMID: 10224285 Free PMC article.

9

Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.

Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H. Kayagaki N, et al. J Immunol. 1999 Aug 15;163(4):1906-13. J Immunol. 1999. PMID: 10438925

10

Cytolytic mechanisms involved in non-MHC-restricted cytotoxicity in Chediak-Higashi syndrome.

Nakazawa T, Agematsu K, Yasui K, Onodera T, Inoue R, Kaneko H, Kondo N, Yamamoto M, Kayagaki N, Yagita H, Okumura K, Komiyama A. Nakazawa T, et al. Among authors: kayagaki n. Clin Exp Immunol. 1999 Oct;118(1):108-14. doi: 10.1046/j.1365-2249.1999.01025.x. Clin Exp Immunol. 1999. PMID: 10540167 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters